{"@type": "dcat:Dataset", "accessLevel": "public", "accrualPeriodicity": "R/P1Y", "bureauCode": ["009:10"], "contactPoint": {"@type": "vcard:Contact", "fn": "Division of Drug Information", "hasEmail": "mailto:druginfo@fda.hhs.gov"}, "description": "GVOKE is a glucagon injection used to treat severe low blood sugar (hypoglycemia) in people with diabetes. It comes in auto-injectors, pre-filled syringes, and kits for subcutaneous or intravenous use. Glucagon works by raising blood sugar levels quickly. This information was generated using AI and is provided for informational and research purposes only.", "distribution": [{"@type": "dcat:Distribution", "description": "\n        Access the FDA dataset for Glucagon injection, solution \u2014 ANDA 212097 submitted by Mylan Institutional LLC\n    ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212097", "mediaType": "text/html", "title": "Glucagon injection, solution"}], "identifier": "ANDA212097", "issued": "2016-09-16", "keyword": ["prescription-drugs", "fda", "drug-information", "drug", "medications"], "landingPage": "https://www.fda.gov/drugs", "license": "https://open.fda.gov/license", "modified": "2025-03-17", "programCode": ["009:002"], "publisher": {"@type": "org:Organization", "name": "U.S. Food and Drug Administration"}, "theme": ["FDA"], "title": "Glucagon injection, solution"}